Varian Medical Systems Inc (VAR) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access VAR quarterly Cash Flow →
Looking at cash flow data from Varian Medical Systems Inc through Sep 30 2016 provides insight into Oct 02 2020's financial flexibility across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Oct 02 2020)
12 Months
(Sep 27 2019) (Sep 28 2018) (Sep 29 2017) (Sep 30 2016)
Operating Activities
Income269.40
Depreciation & amortization60.60
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability58.00
Provision For Loan Losses Expensed14.50
Increase (Decrease) in Inventories39.80
Research and Development in Process0.00
Sale of Assets0.00
Share-based Compensation43.90
Income (Loss) from Equity Method Investments0.00
Tax benefit on stock options0.00
Tax Benefit From Stock Options Exercised-
Change In Fair Value Of Contingent Consideration-
Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities-12.50
Amortization Of Intangible Assets And Inventory Step Up-
Gain On Equity Investments38.30
Income taxes26.90
Gain on Sale of Investments-41.50
Increase (Decrease) in Accounts Receivable35.20
Increase (Decrease) in Accounts Payable-66.90
Accrued liabilities0.00
Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets4.80
Other Working Capital0.00
Other Noncash Income (Expense)2.40
Other net0.00
Payments for (Proceeds from) Other Operating Activities11.20
Discontinued operations0.00
Net Cash flow from Operating Activities484.10
Investing Activities
Capital Expenditures-84.30
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Proceeds from other investments0.00
Investment In Debt Security-
Payments To Acquire Proceeds From Repayment Of Notes Receivable-
Payments For Proceeds From Deferred Compensation Plan Securities Net-
Payments To Acquire Asset And Businesses Net Of Cash Acquired-
Proceeds from Collection of Paymentsto Fund Loansto Affiliated Entities-
Payments To Acquire Equity And Notes Receivable In Privately Held Companies-26.30
Increase (Decrease) in Restricted Cash0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments to Acquire Investments9.20
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-36.20
Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities-2.70
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-140.30
Financing Activities
Short-term debt Net-55.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-10.20
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-27.90
Employees Taxes Withheld And Paid For Restricted Performance Shares Restricted Stock And Restricted Stock Units-
Proceeds From Payments For Equity Forward Contract-
Payment Of Contingent Consideration-
Payment Of Contingent Consideration And Hold Back-
Proceeds From Spinoff-
Contribution Of Cash And Cash Equivalents In Spinoff-
Proceeds From Related Party Discontinued Operations-
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-93.10
Effect of exchange rate on cash flow-9.00
Discontinued operations0.00
Free Cash Flow399.80
Total Cash Flow241.70
4 historic quarters locked

Sign in to unlock the full Varian Medical Systems Inc cash flow history.

About VAR Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License